OPPapers.com

Interclean

Introduction
Gene One, an 8-year-old biotechnology company, has quickly grown to be one of the top players in the biotechnological industry. In just few short years, the company Chief Executive Officer Don Ruiz has led the start up company with the initial two million dollars into a 400 million dollar industry leader. To maintain its position within the industry, Gene One plans to generate the capital through an Initial Public Offering (IPO). However, the rapid expansion the last few years has left Gene One limited time to recruit talents from big corporation whom have experience in complicated IPO process. In addition, Gene One is faced with losing its current scientists and talents due to fear of job stability stemming from the IPO process. In preparation for a successful IPO, Gene One will benchmark other companies that faced similar situations to derive optimal solution for career development, employee retention, organizational communication and corporate structure.
Company
Visa, the world’s largest retail electronic payments network that empowers the global economy by securely transferring trillions of dollars in more than 170 countries worldwide.
Issue
For more than 30 years, Visa has pioneered the migration to electronic payments from cash and checks (Visa, 2008). To increase its market share in a furious competitive industry and to compete with its main rival MasterCard which went public in 2006, Visa would need capital from an IPO to invest in the company business model as well as in its organization and employees. To ensure a successful IPO, the company encompassed a team of experts with legal and compliance expertise as well as solid pre-IPO and post-IPO strategies to gain trust and build creditability with its employees, its investors and its consumers or clients.
Alternative Solution
Visa just recently went through the IPO process in March 2008. Due to the anti-trust lawsuits brought towards Visa, it spent years taking...